- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
New Reimbursement Provisions a Big Boost for the Diet Industry
The lack of attention by mainstream medicine to the problems of overweight or obese patients have contributed to the burgeoning diet industry.
As obesity is increasingly being recognized as the underlying cause of many a disease, healthcare plans have changed their approach to the condition, especially folowing a provision within the Affordable Care Act. Insurers are now mandated to cover nutrition and obesity screening for their enrollees.
This has created a tremendous opportunity for diet clinics and resulted in an industry of sorts, which sometimes uses as yet unproven treatments like vitamin injections or dietary supplements that may not have been validated. The lack of attention by mainstream medicine to the problems of overweight or obese patients may have contributed to the burgeoning diet industry, says an article in The New York Times.
Survival, PROs Favor Cemiplimab Plus Chemotherapy vs Chemotherapy Alone in Advanced NSCLC
December 4th 2023For patients with advanced non–small cell lung cancer (NSCLC), regardless of PD-L1 status, cemiplimab plus chemotherapy had favorable survival benefits and patient-reported outcomes over chemotherapy alone.
Read More
SABCS 2023 Sessions Touch on "Every Aspect of Breast Cancer"
December 4th 2023The 46th annual San Antonio Breast Cancer Symposium will take place December 5-9, with new and experienced attendees able to choose and learn from a schedule overflowing with the latest developments in breast cancer science and research.
Read More
